Readout Capital

Readout Capital is an emerging biotech investment manager. Our principals have extensive experience investing in the life sciences sector, with a focus on what we believe are overlooked and out-of-favor value opportunities in biotech and pharmaceuticals. We seek to generate absolute returns across market cycles by combining our value-oriented investment philosophy with scientific access to the ecosystem of drug development.